A detailed history of Transamerica Financial Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Transamerica Financial Advisors, Inc. holds 287 shares of PFE stock, worth $7,565. This represents 0.0% of its overall portfolio holdings.

Number of Shares
287
Previous 42,292 99.32%
Holding current value
$7,565
Previous $1.18 Million 99.24%
% of portfolio
0.0%
Previous 0.13%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $1.16 Million - $1.32 Million
-42,005 Reduced 99.32%
287 $9,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $511,042 - $586,840
-19,739 Reduced 31.82%
42,292 $1.17 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $479,642 - $623,002
-18,356 Reduced 22.83%
62,031 $1.79 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $227,518 - $265,945
-7,090 Reduced 8.1%
80,387 $2.67 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $82,425 - $95,364
2,282 Added 2.68%
87,477 $3.21 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $349,349 - $454,802
8,869 Added 11.62%
85,195 $3.48 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $373,036 - $486,957
8,935 Added 13.26%
76,326 $3.91 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $183,835 - $224,417
4,201 Added 6.65%
67,391 $2.95 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $2.94 Million - $3.49 Million
63,177 Added 485976.91%
63,190 $3.31 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $82 - $122
-2 Reduced 13.33%
13 $1,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $196 - $252
-5 Reduced 25.0%
15 $1,000
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $133 - $151
4 Added 25.0%
20 $1,000
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $435 - $553
-13 Reduced 44.83%
16 $1,000
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $232,981 - $273,340
-7,338 Reduced 99.61%
29 $2,000
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $221,894 - $269,190
7,367 New
7,367 $241,000
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $143,410 - $185,961
-4,414 Closed
0 $0
Q2 2019

Aug 21, 2019

BUY
$36.98 - $41.52 $163,229 - $183,269
4,414 New
4,414 $192,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $96,112 - $105,595
-2,563 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$38.47 - $43.86 $35,123 - $40,044
913 Added 55.33%
2,563 $112,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $48,775 - $59,161
1,415 Added 602.13%
1,650 $73,000
Q2 2018

Jul 25, 2018

SELL
$32.98 - $35.16 $6.71 Million - $7.16 Million
-203,566 Reduced 99.88%
235 $9,000
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $490,009 - $568,479
-15,356 Reduced 7.01%
203,801 $7.23 Million
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $103,106 - $109,399
-3,100 Reduced 1.39%
219,157 $7.94 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $6.89 Million - $7.59 Million
222,257
222,257 $7.94 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Transamerica Financial Advisors, Inc. Portfolio

Follow Transamerica Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.